The Dosimetry Core Unit (DCU) supports collaborative dosimetry research to enable consistently effective and safe radionuclide therapy. To this aim, we perform translational research, covering the whole range from bench to bedside to community. Knowledge and expertise is used within the DCU to work on three important sub-goals:

Personalized Dose Calculation

Accurate absorbed dose calculations for safe and effective radionuclide therapy for personalized treatment in patients.

Tracer and Method Development

Development of new suitable tracers for radionuclide therapy, photodynamic therapy and pre-clinical dosimetry.

Dose-Effect Biology

Obtaining fundamental knowledge about dose-effect relationships.